Naringenin
Naringenin is a bioflavonoid drug potentially for the treatment of HCV infection. has antioxidant and chelating effects in the liver. Naringenin significantly suppressed UVB-induced extracellular signal-regulated kinase 2 (ERK2) activity and subsequently attenuated UVB-induced phosphorylation of p90 (RSK) by competitively binding with ATP. Naringenin exerts potent anti-photoaging effects by suppressing ERK2 activity and decreasing FRA1 stability, followed by down-regulation of AP-1 transactivation and MMP-1 expression. Naringenin blocks TGF-β1 trafficking from the trans-Golgi network by suppressing PKC activity, resulting in a reduction of TGF-β1 secretion from breast cancer cells.
Product Specifications
CAS Number
480-41-1
Product Name Alternative
Naringenin | NSC 11855 | NSC-11855 | NSC11855
Purity
>98% (HPLC)
Solubility
DMSO : ≥ 50 mg/mL; 183.65 mM
Smiles
C1[C@H] (Oc2cc (cc (c2C1=O) O) O) c1ccc (cc1) O
Molecular Formula
C15H12O5
Molecular Weight
272.26
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
(S) -5,7-dihydroxy-2- (4-hydroxyphenyl) chroman-4-one
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Recombinant Escherichia coli O8 UPF0060 membrane protein ynfA (ynfA)
Recombinant Escherichia coli O8 UPF0060 membrane protein ynfA (ynfA)
